Multimodal imaging in a severe case of hydroxychloroquine toxicity.

Retinal toxicity from hydroxychloroquine (HCQ) can be detected most readily on fundus autofluorescence, spectral-domain optical coherence tomography, and multifocal electroretinogram. The authors describe a case of a 60-year-old woman with a history of systemic lupus erythematosus undergoing HCQ treatment for 30 years who presented with visual loss over several years. Examination and multimodal imaging showed bilateral retinal pigment epithelium (RPE) changes in a bull's-eye distribution associated with cystoid macular edema. A novel imaging modality, multi-spectral imaging, appeared sensitive in detecting a bull's-eye pattern of RPE disturbance involving the entire macular region of both eyes. Cessation of drug was advised with close follow-up.

[1]  U. Kellner,et al.  Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation , 2013, British Journal of Ophthalmology.

[2]  S. Tsang,et al.  Retinal Damage in Chloroquine Maculopathy, Revealed by High Resolution Imaging: A Case Report Utilizing Adaptive Optics Scanning Laser Ophthalmoscopy , 2014, Korean journal of ophthalmology : KJO.

[3]  M. Marmor,et al.  Effect of disease stage on progression of hydroxychloroquine retinopathy. , 2014, JAMA ophthalmology.

[4]  M. Marmor,et al.  Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. , 2002, Ophthalmology.

[5]  Petros P Sfikakis,et al.  The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. , 2003, Ophthalmology.

[6]  T. Olsen,et al.  Hydroxychloroquine retinopathy screening , 2008, British Journal of Ophthalmology.

[7]  R. Carr,et al.  Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. , 2002, Ophthalmology.

[8]  M. Marmor,et al.  Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. , 2014, Ophthalmology.

[9]  J. S. Lyons Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. , 2013, American journal of ophthalmology.

[10]  H. Walia,et al.  Hydrochloroquine retinopathy: characteristic presentation with review of screening , 2013, Clinical Rheumatology.